Zenas Biopharma’s (ZBIO) “Outperform” Rating Reiterated at Wedbush
Wedbush reiterated their outperform rating on shares of Zenas Biopharma (NASDAQ:ZBIO – Free Report) in a report published on Thursday morning,RTT News reports. Wedbush currently has a $35.00 price target on the stock. Wedbush also issued estimates for Zenas Biopharma’s FY2027 earnings at ($3.71) EPS. Separately, Guggenheim reaffirmed a “buy” rating and set a $45.00 […]
Wedbush reiterated their outperform rating on shares of Zenas Biopharma (NASDAQ:ZBIO – Free Report) in a report published on Thursday morning,RTT News reports. Wedbush currently has a $35.00 price target on the stock. Wedbush also issued estimates for Zenas Biopharma’s FY2027 earnings at ($3.71) EPS. Separately, Guggenheim reaffirmed a “buy” rating and set a $45.00 […]
